CHI3L1 and Alzheimer disease: Although 11 studies measuring YKL-40 levels met inclusion criteria, data from one of these studies were a significant outlier and were not included in the meta-analysis.23 Specifically, the study reported a SD for the AD and CU group's YKL-40 levels 2 orders of magnitude smaller than expected based on all other studies.